晚期结直肠癌-话题@MedSci

#晚期结直肠癌#

32篇内容 | 979人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1985955, encodeId=0158198595500, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=晚期结直肠癌患者可受益于奥沙利铂的短周期治疗, objectType=article, longId=127967, objectId=b11012e967a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b11012e967a8, replyNumber=0, likeNumber=0, createdTime=2018-03-28, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b11012e967a8, moduleTitle=晚期结直肠癌患者可受益于奥沙利铂的短周期治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b11012e967a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985953, encodeId=f61f19859534b, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=SCI REP：代谢异常是晚期结直肠癌发生的一个重要预测因子！, objectType=article, longId=110490, objectId=e55a11049004, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e55a11049004, replyNumber=0, likeNumber=28, createdTime=2017-10-12, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e55a11049004, moduleTitle=SCI REP：代谢异常是晚期结直肠癌发生的一个重要预测因子！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e55a11049004)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985954, encodeId=68f1198595482, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=张艳桥教授 | （K）RAS突变型晚期结直肠癌的治疗, objectType=article, longId=123335, objectId=b8531233359c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8531233359c, replyNumber=0, likeNumber=20, createdTime=2017-12-22, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8531233359c, moduleTitle=张艳桥教授 | （K）RAS突变型晚期结直肠癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8531233359c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985952, encodeId=c6911985952ee, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=晚期结直肠癌的免疫治疗解读, objectType=article, longId=86675, objectId=b14f866e523, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b14f866e523, replyNumber=0, likeNumber=34, createdTime=2017-07-10, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b14f866e523, moduleTitle=晚期结直肠癌的免疫治疗解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b14f866e523)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985951, encodeId=58fa198595170, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=FDA批准TAS-102(Lonsurf)用于治疗晚期结直肠癌, objectType=article, longId=56824, objectId=8f225682468, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f225682468, replyNumber=0, likeNumber=29, createdTime=2015-12-15, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f225682468, moduleTitle=FDA批准TAS-102(Lonsurf)用于治疗晚期结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f225682468)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985950, encodeId=eb1e1985950bf, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=ASCO GI 2015：徐瑞华：Famitinib可改善晚期结直肠癌患者PFS, objectType=article, longId=45867, objectId=ab984586ebc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab984586ebc, replyNumber=0, likeNumber=30, createdTime=2015-03-20, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab984586ebc, moduleTitle=ASCO GI 2015：徐瑞华：Famitinib可改善晚期结直肠癌患者PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab984586ebc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985949, encodeId=c5fc1985949f1, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=CSCO 2014：晚期结直肠癌分子靶向治疗进展, objectType=article, longId=40529, objectId=0e03405298b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e03405298b, replyNumber=0, likeNumber=34, createdTime=2015-07-30, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e03405298b, moduleTitle=CSCO 2014：晚期结直肠癌分子靶向治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e03405298b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985948, encodeId=2f1c19859485e, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=ASCO 2014：李进教授证实呋喹替尼治疗晚期结直肠癌安全有效, objectType=article, longId=35257, objectId=8d7a3525ed0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d7a3525ed0, replyNumber=0, likeNumber=38, createdTime=2014-10-14, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d7a3525ed0, moduleTitle=ASCO 2014：李进教授证实呋喹替尼治疗晚期结直肠癌安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d7a3525ed0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985947, encodeId=d084198594e2b, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=陈功：晚期结直肠癌中颠覆三观的FIRE-3研究, objectType=article, longId=26746, objectId=bc0c26e4681, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0c26e4681, replyNumber=0, likeNumber=35, createdTime=2014-08-15, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0c26e4681, moduleTitle=陈功：晚期结直肠癌中颠覆三观的FIRE-3研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0c26e4681)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985946, encodeId=b349198594638, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=研究汇总：转移瘤不可切除的晚期结直肠癌原发瘤切除的共识与争议, objectType=article, longId=24535, objectId=b36f245353c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b36f245353c, replyNumber=0, likeNumber=27, createdTime=2014-05-15, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b36f245353c, moduleTitle=研究汇总：转移瘤不可切除的晚期结直肠癌原发瘤切除的共识与争议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b36f245353c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985945, encodeId=2e97198594569, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=王锡山：晚期结直肠癌外科治疗策略的思考, objectType=article, longId=4950, objectId=a436495065, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a436495065, replyNumber=0, likeNumber=39, createdTime=2012-07-07, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a436495065, moduleTitle=王锡山：晚期结直肠癌外科治疗策略的思考, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a436495065)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985944, encodeId=a00e19859445f, content=<a href='/topic/show?id=86fd59855df' target=_blank style='color:#2F92EE;'>#晚期结直肠癌#</a>, objectTitle=李进：2011年晚期结直肠癌内科治疗进展, objectType=article, longId=3945, objectId=608f39457b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=608f39457b, replyNumber=0, likeNumber=42, createdTime=2012-04-30, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=608f39457b, moduleTitle=李进：2011年晚期结直肠癌内科治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=608f39457b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

晚期结直肠癌

2020-05-29

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

晚期结直肠癌患者可受益于奥沙利铂的短周期治疗

2018-03-28

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

SCI REP：代谢异常是晚期结直肠癌发生的一个重要预测因子！

2017-10-12

仁医06 (审核中...)

前往app查看评论内容

#晚期结直肠癌#

张艳桥教授 | （K）RAS突变型晚期结直肠癌的治疗

2017-12-22

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

晚期结直肠癌的免疫治疗解读

2017-07-10

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

FDA批准TAS-102(Lonsurf)用于治疗晚期结直肠癌

2015-12-15

huagfeg (审核中...)

前往app查看评论内容

#晚期结直肠癌#

ASCO GI 2015：徐瑞华：Famitinib可改善晚期结直肠癌患者PFS

2015-03-20

智智灵药 (审核中...)

前往app查看评论内容

#晚期结直肠癌#

CSCO 2014：晚期结直肠癌分子靶向治疗进展

2015-07-30

智智灵药 (审核中...)

前往app查看评论内容

#晚期结直肠癌#

ASCO 2014：李进教授证实呋喹替尼治疗晚期结直肠癌安全有效

2014-10-14

智智灵药 (审核中...)

前往app查看评论内容

#晚期结直肠癌#

陈功：晚期结直肠癌中颠覆三观的FIRE-3研究

2014-08-15

智智灵药 (审核中...)

前往app查看评论内容

#晚期结直肠癌#

研究汇总：转移瘤不可切除的晚期结直肠癌原发瘤切除的共识与争议

2014-05-15

智智灵药 (审核中...)

前往app查看评论内容

#晚期结直肠癌#

王锡山：晚期结直肠癌外科治疗策略的思考

2012-07-07

智智灵药 (审核中...)

前往app查看评论内容

#晚期结直肠癌#

李进：2011年晚期结直肠癌内科治疗进展

2012-04-30

科室
- - 订阅+
  - 更多科室
工具
服务